BMEZ BlackRock Health Sciences Term Trust - Fundamental Analysis
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E, PEG, Graham Number
- No P/E, P/B, or PEG ratios available
- Graham Number and Intrinsic Value undefined
- No valuation benchmarks to assess cheapness
Ref Growth rates
- Sector exposure to health sciences, a potentially growing field
- No revenue or earnings growth data available
- No forward P/E or growth guidance
- Unclear reinvestment or capital allocation strategy
Ref Historical trends
- 3-year return of +31.8% outperforms many peers
- 6-month return of +16.6% shows recent strength
- 5-year return of -15.2% indicates long-term underperformance
- Price near 52-week low of $12.58, recently recovered
Ref Altman Z-Score, Piotroski F-Score
- Piotroski F-Score of 1/9 (critically weak)
- All profitability margins at 0.00%
- No ROE, ROA, or ROIC data
- No debt/equity or liquidity ratios available
Ref Yield, Payout
- High current yield of 8.49%
- Payout ratio of 846.82% is unsustainable
- No data on dividend growth or consistency
- Dividend strength score of only 40/100
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for BMEZ and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
BMEZ
BlackRock Health Sciences Term Trust
Primary
|
-15.2% | +31.8% | +7.0% | +16.6% | +2.9% | +1.9% |
|
BSTZ
BlackRock Science and Technology Term Trust
Peer
|
+4.5% | +76.4% | +17.1% | +13.7% | -0.8% | -0.1% |
|
BFC
Bank First Corporation
Peer
|
+120.4% | +89.8% | +41.8% | +9.5% | +7.0% | +6.0% |
|
BCAT
BlackRock Capital Allocation Term Trust
Peer
|
+28.2% | +62.6% | +16.7% | +9.3% | +5.2% | +0.9% |
|
BITF
Bitfarms Ltd.
Peer
|
+20.7% | +142.5% | +70.2% | +122.8% | +2.6% | -7.1% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Services Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
BMEZ
BlackRock Health Sciences...
|
BEARISH | $1.57B | - | -% | -% | $15.54 | |
|
BSTZ
BlackRock Science and...
|
BEARISH | $1.6B | 3.64 | -% | -% | $22.64 | |
|
BFC
Bank First Corporation
|
NEUTRAL | $1.54B | 19.13 | 11.2% | 41.9% | $137.32 | |
|
BCAT
BlackRock Capital...
|
BEARISH | $1.54B | 9.72 | -% | -% | $14.67 | |
|
BITF
Bitfarms Ltd.
|
BEARISH | $1.64B | - | -12.5% | -46.4% | $2.74 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-19 | FAIRBAIRN ROBERT WILLIAM | Director | Sale | 20,588 | $308,421 |
Past News Coverage
Recent headlines mentioning BMEZ from our newsroom.